Eczema study looks at blood signals to unlock disease secrets
NCT ID NCT05868824
First seen Apr 10, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study aims to better understand the immune response in the blood of people with atopic dermatitis (eczema). Researchers will collect blood samples from about 30 adults with moderate to severe eczema and stimulate the blood with immune triggers to measure cytokine levels. The goal is to see how these immune markers change over time and relate to treatment response, but no new treatment is being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nice University Hospital
Nice, France, 06200, France
Conditions
Explore the condition pages connected to this study.